Neuronal HIF-1α and HIF-2α deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 1, 2017, Pages 291-306

  Barteczek, Philipp ^a   Li, Lexiao ^a   Ernst, Anne Sophie ^a   Böhler, Laura Inés ^a   Marti, Hugo H ^a   Kunze, Reiner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Erythropoietin; hypoxia inducible factor; ischemia; stroke; vascular endothelial growth factor

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; ERYTHROPOIETIN; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PMAIP1 PROTEIN; PROTEIN; PROTEIN BNIP3; UNCLASSIFIED DRUG; VASCULOTROPIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; HIF1A PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BODY WEIGHT; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL LOSS; CELL SURVIVAL; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; FOREBRAIN; GENE CONTROL; GENE EXPRESSION; MACROPHAGE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR ACTIVITY; MOUSE; NERVE CELL; NONHUMAN; OXYGEN TENSION; POSTERIOR COMMUNICATING ARTERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SENSORIMOTOR FUNCTION; SUPERIOR CEREBELLAR ARTERY; TUNEL ASSAY; UPREGULATION; ACUTE DISEASE; ANIMAL; CEREBROVASCULAR ACCIDENT; CYTOLOGY; DEFICIENCY; GENE EXPRESSION REGULATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SENSORIMOTOR CORTEX; TIME FACTOR;

ACUTE DISEASE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN ISCHEMIA; CELL SURVIVAL; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, KNOCKOUT; NEURONS; SENSORIMOTOR CORTEX; STROKE; TIME FACTORS;

EID: 85006409435     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X15624933     Document Type: Article

References (58)

1. Kaelin WG Jr. and Ratcliffe PJ. Oxygen sensing by meta-zoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30: 393-402.
2. Althaus J, Bernaudin M, Petit E, et al. Expression of the gene encoding the pro-apoptotic BNIP3 protein and stimulation of hypoxia-inducible factor-1alpha (HIF-1alpha) protein following focal cerebral ischemia in rats. Neurochem Int 2006; 48: 687-695.
3. Bruick RK. Expression of the gene encoding the proapop-totic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000; 97: 9082-9087.
4. Kim JY, Ahn HJ, Ryu JH, et al. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 2004; 199: 113-124.
5. Baranova O, Miranda LF, Pichiule P, et al. Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 2007; 27: 6320-6332.
6. Helton R, Cui J, Scheel JR, et al. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 2005; 25: 4099-4107.
7. Hu CJ, Sataur A, Wang L, et al. The N-terminal trans-activation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 2007; 18: 4528-4542.
8. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54.
9. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-468.
10. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472.
11. Lando D, Peet DJ, Gorman JJ, et al. FIH-1 is an aspar-aginyl hydroxylase enzyme that regulates the transcrip-tional activity of hypoxia-inducible factor. Genes Dev 2002; 16: 1466-1471.
12. Lando D, Peet DJ, Whelan DA, et al. Asparagine hydroxylation of the HIF transactivation domain a hyp-oxic switch. Science 2002; 295: 858-861.
13. Chen RL, Ogunshola OO, Yeoh KK, et al. HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice. J Neurochem 2014; 131: 177-189.
14. Nagel S, Papadakis M, Chen R, et al. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2011; 31: 132-143.
15. Ogle ME, Gu X, Espinera AR, et al. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia indu-cible factor-1alpha. Neurobiol Dis 2012; 45: 733-742.
16. Prass K, Ruscher K, Karsch M, et al. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 2002; 22: 520-525.
17. Reischl S, Li L, Walkinshaw G, et al. Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke. PLoS One 2014; 9: e84767.
18. Siddiq A, Ayoub IA, Chavez JC, et al. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neu-roprotection in the central nervous system. J Biol Chem 2005; 280: 41732-41743.
19. Zhao Y and Rempe DA. Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with defer-oxamine or deferasirox establishes prolonged neuropro-tection independent of HIF-1 function. J Cereb Blood Flow Metab 2011; 31: 1412-1423.
20. Bernaudin M, Nedelec AS, Divoux D, et al. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythro-poietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002; 22: 393-403.
21. Leconte C, Tixier E, Freret T, et al. Delayed hypoxic postconditioning protects against cerebral ischemia in the mouse. Stroke 2009; 40: 3349-3355.
22. Miller BA, Perez RS, Shah AR, et al. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 2001; 12: 1663-1669.
23. Prass K, Scharff A, Ruscher K, et al. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoi-etin. Stroke 2003; 34: 1981-1986.
24. Ryan HE, Poloni M, McNulty W, et al. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 2000; 60: 4010-4015.
25. Gruber M, Hu CJ, Johnson RS, et al. Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci USA 2007; 104: 2301-2306.
26. Casanova E, Fehsenfeld S, Mantamadiotis T, et al. A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Genesis 2001; 31: 37-42.
27. Kunze R, Zhou W, Veltkamp R, et al. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia. Stroke 2012; 43: 2748-2756.
28. Schoch HJ, Fischer S and Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002; 125(Pt 11): 2549-2557.
29. Lubjuhn J, Gastens A, von Wilpert G, et al. Functional testing in a mouse stroke model induced by occlusion of the distal middle cerebral artery. J Neurosci Methods 2009; 184: 95-103.
30. Zhang L, Schallert T, Zhang ZG, et al. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 2002; 117: 207-214.
31. Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-476.
32. Limbourg A, Korff T, Napp LC, et al. Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc 2009; 4: 1737-1746.
33. Wiesener MS, Jurgensen JS, Rosenberger C, et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003; 17: 271-273.
34. Rabie T and Marti HH. Brain protection by erythropoi-etin: a manifold task. Physiology (Bethesda) 2008; 23: 263-274.
35. Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotec-tion, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111: 1843-1851.
36. Bergeron M, Yu AY, Solway KE, et al. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999; 11: 4159-4170.
37. Sharp FR, Bergeron M and Bernaudin M. Hypoxia-indu-cible factor in brain. Adv Exp Med Biol 2001; 502: 273-291.
38. Haase VH. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev 2013; 27: 41-53.
39. Barone FC, Knudsen DJ, Nelson AH, et al. Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy. J Cereb Blood Flow Metab 1993; 13: 683-692.
40. Kitagawa K, Matsumoto M, Yang G, et al. Cerebral ischemia after bilateral carotid artery occlusion and intra-luminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery. J Cereb Blood Flow Metab 1998; 18: 570-579.
41. Ozdemir YG, Bolay H, Erdem E, et al. Occlusion of the MCA by an intraluminal filament may cause disturbances in the hippocampal blood flow due to anomalies of circle of Willis and filament thickness. Brain Res 1999; 822: 260-264.
42. Sowter HM, Ratcliffe PJ, Watson P, et al. HIF-1-depen-dent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001; 61: 6669-6673.
43. Bernaudin M, Marti HH, Roussel S, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999; 19: 643-651.
44. Wang Y, Kilic E, Kilic U, et al. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 2005; 128(Pt 1): 52-63.
45. Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-838.
46. Menrad H, Werno C, Schmid T, et al. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids. Hepatology 2010; 51: 2183-2192.
47. Raval RR, Lau KW, Tran MG, et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005; 25: 5675-5686.
48. Yeo EJ, Cho YS, Kim MS, et al. Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: in vivo evidence based on chromatin immunoprecipita-tion. Ann Hematol 2008; 87: 11-17.
49. Chavez JC, Baranova O, Lin J, et al. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoi-etin in cortical astrocytes. J Neurosci 2006; 26: 9471-9481.
50. Stiehl DP, Bordoli, Abreu-Rodriguez I, et al. Non-cano-nical HIF-2alpha function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Oncogene 2012; 31: 2283-2297.
51. Issa R, Krupinski J, Bujny T, et al. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest 1999; 79: 417-425.
52. Kovacs Z, Ikezaki K, Samoto K, et al. VEGF and flt. Expression time kinetics in rat brain infarct. Stroke 1996; 27: 1865-1873.
53. Zhang Z, Yang X, Zhang S, et al. BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia. Stroke 2007; 38: 1606-1613.
54. Shi RY, Zhu SH, Li V, et al. BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci Ther 2014; 20: 1045-1055.
55. Chen C, Hu Q, Yan J, et al. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1alpha and apop-totic genes in a middle cerebral artery occlusion-induced focal ischemia rat model. J Neurochem 2007; 102: 1831-1841.
56. Chen C, Hu Q, Yan J, et al. Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 2009; 33: 509-517.
57. Birse-Archbold JL, Kerr LE, Jones PA, et al. Differential profile of Nix upregulation and translocation during hyp-oxia/ischaemia in vivo versus in vitro. J Cereb Blood Flow Metab 2005; 25: 1356-1365.
58. Greenberg DA and Jin K. Vascular endothelial growth factors (VEGFs) and stroke. Cell Mol Life Sci 2013; 70: 1753-1761.